These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32320050)

  • 1. 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.
    Fiala EM; Ortiz MV; Kennedy JA; Glodzik D; Fleischut MH; Duffy KA; Hathaway ER; Heaton T; Gerstle JT; Steinherz P; Shukla N; McNeer N; Tkachuk K; Bouvier N; Cadoo K; Carlo MI; Latham A; Dubard Gault M; Joseph V; Kemel Y; Kentsis A; Stadler Z; La Quaglia M; Papaemmanuil E; Friedman D; Ganguly A; Kung A; Offit K; Kalish JM; Walsh MF
    Cancer; 2020 Jul; 126(13):3114-3121. PubMed ID: 32320050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma.
    Pilet J; Hirsch TZ; Gupta B; Roehrig A; Morcrette G; Pire A; Letouzé E; Fresneau B; Taque S; Brugières L; Branchereau S; Chardot C; Aerts I; Sarnacki S; Fabre M; Guettier C; Rebouissou S; Zucman-Rossi J
    Nat Commun; 2023 Nov; 14(1):7122. PubMed ID: 37932266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent Hepatoblastoma and Wilms Tumor Leading to Diagnosis of Beckwith-Wiedemann Syndrome.
    Wolfe DM; Webster Carrion A; Masukhani MM; Oberg JA; Pavisic J; El-Ali A; Gupta M; Weng K; Glasser CL
    J Pediatr Hematol Oncol; 2023 May; 45(4):e525-e529. PubMed ID: 36730589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors.
    O'Keefe D; Dao D; Zhao L; Sanderson R; Warburton D; Weiss L; Anyane-Yeboa K; Tycko B
    Am J Hum Genet; 1997 Aug; 61(2):295-303. PubMed ID: 9311733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel deletion in 11p15.5 imprinting center region 1 in a patient with Beckwith-Wiedemann syndrome provides insight into distal enhancer regulation and tumorigenesis.
    Bachmann N; Crazzolara R; Bohne F; Kotzot D; Maurer K; Enklaar T; Prawitt D; Bergmann C
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1.
    Weksberg R; Nishikawa J; Caluseriu O; Fei YL; Shuman C; Wei C; Steele L; Cameron J; Smith A; Ambus I; Li M; Ray PN; Sadowski P; Squire J
    Hum Mol Genet; 2001 Dec; 10(26):2989-3000. PubMed ID: 11751681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms tumour in Beckwith-Wiedemann Syndrome and loss of methylation at imprinting centre 2: revisiting tumour surveillance guidelines.
    Brzezinski J; Shuman C; Choufani S; Ray P; Stavropoulos DJ; Basran R; Steele L; Parkinson N; Grant R; Thorner P; Lorenzo A; Weksberg R
    Eur J Hum Genet; 2017 Sep; 25(9):1031-1039. PubMed ID: 28699632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcifying nested stromal-epithelial tumor (CNSET) of the liver in Beckwith-Wiedemann syndrome.
    Khoshnam N; Robinson H; Clay MR; Schaffer LR; Gillespie SE; Shehata BM
    Eur J Med Genet; 2017 Feb; 60(2):136-139. PubMed ID: 27965001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription alterations of KCNQ1 associated with imprinted methylation defects in the Beckwith-Wiedemann locus.
    Valente FM; Sparago A; Freschi A; Hill-Harfe K; Maas SM; Frints SGM; Alders M; Pignata L; Franzese M; Angelini C; Carli D; Mussa A; Gazzin A; Gabbarini F; Acurzio B; Ferrero GB; Bliek J; Williams CA; Riccio A; Cerrato F
    Genet Med; 2019 Aug; 21(8):1808-1820. PubMed ID: 30635621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome.
    Gaston V; Le Bouc Y; Soupre V; Burglen L; Donadieu J; Oro H; Audry G; Vazquez MP; Gicquel C
    Eur J Hum Genet; 2001 Jun; 9(6):409-18. PubMed ID: 11436121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor.
    Scott RH; Douglas J; Baskcomb L; Huxter N; Barker K; Hanks S; Craft A; Gerrard M; Kohler JA; Levitt GA; Picton S; Pizer B; Ronghe MD; Williams D; ; Cook JA; Pujol P; Maher ER; Birch JM; Stiller CA; Pritchard-Jones K; Rahman N
    Nat Genet; 2008 Nov; 40(11):1329-34. PubMed ID: 18836444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children with idiopathic hemihypertrophy and beckwith-wiedemann syndrome have different constitutional epigenotypes associated with wilms tumor.
    Niemitz EL; Feinberg AP; Brandenburg SA; Grundy PE; DeBaun MR
    Am J Hum Genet; 2005 Nov; 77(5):887-91. PubMed ID: 16252245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of molecular studies in the long-term follow-up of children with beckwith- wiedemann syndrome.
    Gizewska M; Wilk M; Patalan M; Mackay D; Peregud-Pegorzelski J; Gawrych E; Walczak M; Petriczko E; Brodkiewicz A
    Turk J Pediatr; 2014; 56(2):177-82. PubMed ID: 24911853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive and quantitative multilocus methylation analysis reveals the susceptibility of specific imprinted differentially methylated regions to aberrant methylation in Beckwith-Wiedemann syndrome with epimutations.
    Maeda T; Higashimoto K; Jozaki K; Yatsuki H; Nakabayashi K; Makita Y; Tonoki H; Okamoto N; Takada F; Ohashi H; Migita M; Kosaki R; Matsubara K; Ogata T; Matsuo M; Hamasaki Y; Ohtsuka Y; Nishioka K; Joh K; Mukai T; Hata K; Soejima H
    Genet Med; 2014 Dec; 16(12):903-12. PubMed ID: 24810686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple genetic abnormalities of 11p15 in Wilms' tumor.
    Feinberg AP
    Med Pediatr Oncol; 1996 Nov; 27(5):484-9. PubMed ID: 8827078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved molecular detection of mosaicism in Beckwith-Wiedemann Syndrome.
    Baker SW; Duffy KA; Richards-Yutz J; Deardorff MA; Kalish JM; Ganguly A
    J Med Genet; 2021 Mar; 58(3):178-184. PubMed ID: 32430359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour.
    Cerrato F; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Rinaldi MM; Boccuto L; Neri G; Magnani C; D'Angelo P; Collini P; Perotti D; Sebastio G; Maher ER; Riccio A
    Hum Mol Genet; 2008 May; 17(10):1427-35. PubMed ID: 18245780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome.
    Cooper WN; Luharia A; Evans GA; Raza H; Haire AC; Grundy R; Bowdin SC; Riccio A; Sebastio G; Bliek J; Schofield PN; Reik W; Macdonald F; Maher ER
    Eur J Hum Genet; 2005 Sep; 13(9):1025-32. PubMed ID: 15999116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epigenetic imprinting defect of patients with Beckwith-Wiedemann syndrome born after assisted reproductive technology is not restricted to the 11p15 region.
    Rossignol S; Steunou V; Chalas C; Kerjean A; Rigolet M; Viegas-Pequignot E; Jouannet P; Le Bouc Y; Gicquel C
    J Med Genet; 2006 Dec; 43(12):902-7. PubMed ID: 16825435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype evolution and health issues of adults with Beckwith-Wiedemann syndrome.
    Gazzin A; Carli D; Sirchia F; Molinatto C; Cardaropoli S; Palumbo G; Zampino G; Ferrero GB; Mussa A
    Am J Med Genet A; 2019 Sep; 179(9):1691-1702. PubMed ID: 31339634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.